Shanghai Xinzemu Biotechnology Co., LTD., founded in 2018, is a high-tech enterprise focusing on the field of life science, committed to the research and development, testing, production, sales and technical services of cell culture products (certificate number: GR202331007190), and in 2023 by the Shanghai "specialized and special" enterprise identification.

Located in Songjiang District, Shanghai, the company has a testing space of more than 1000 square meters, with an independent molecular biology and 3 cell culture laboratories, which can provide strong support for product development, quality control and customer service.

At present, the company mainly produces bovine serum and cell culture kits and other products, with a maximum single batch production capacity of 1000L and an annual production capacity of 100 tons. The company strictly follows the quality management system to ensure that every link meets international standards. The products are widely used in medical research, drug development and bioengineering.

At present, it holds a production plant of about 4000 square meters in Fengxian, Shanghai, which will be the main production base of the company in the future.

The company plans to have production and processing lines of bovine serum, bovine serum albumin, cell culture kits, cell lines and related cell culture technical service platforms. Currently in the pre-renovation design phase, it is expected to be put into use in 2024. The plan is to provide customers with high-quality and more comprehensive integrated cell culture solutions through supporting more advanced production facilities and stricter quality control.